ERBB2 and neoplasm: Most of the included variables used to adjust the multivariate analysis were the commonly reported biomarkers (ER, PR, HER2, and Ki-67), age, tumour size and grade, age at diagnosis, lymph node stage, histological grade, body mass index (BMI), chemotherapy regimens, chemotherapy cycles, and other biomarkers and genetic variations unique to the study.